(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

CONJUGADO DERIVADO DE PIRROLOBENZODIAZEPINA-ANTICORPO

Em AnáliseInvention PatentPCT · IB2022050219

Application data

Number

112023013840

Type

Invention Patent

Filing

01/13/2022

Publication

08/08/2023

PCT

IB2022050219

Progress at the INPI

  1. Filing01/13/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 01/13/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 08/08/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

DAIICHI SANKYO COMPANY, LIMITED

JP

M. C. (pessoa física)

US

TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE

US

See this company's full portfolio

Inventors

A. K. (pessoa física)

US

C. R. (pessoa física)

US

D. A. (pessoa física)

US

H. M. (pessoa física)

JP

I. L. (pessoa física)

US

J. L. (pessoa física)

US

J. P. (pessoa física)

US

X. C. (pessoa física)

US

Technical data

Priority claims

US

63/136,928 · 01/13/2021

Abstract

CONJUGADO DERIVADO DE PIRROLOBENZODIAZEPINA-ANTICORPO. A presente invenção fornece um novo derivado de pirrolodiazepina-anticorpo anti-DLL3 e um novo conjugado do derivado pirrolodiazepina-anticorpo anti-DLL3 usando o mesmo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

08/08/2023

RPI 2744

Alteração de dados cadastrais

#1.1

07/18/2023

RPI 2741

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.